Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Semeraro

Showing results (111-120 of 130) with videos related to

Pageof 13
Sort By:
Journal of Thrombosis and Haemostasis : JTH|April 21, 2016
Reduced fibrinolytic resistance in patients with factor XI deficiency. Evidence of a thrombin-independent impairment of the thrombin-activatable fibrinolysis inhibitor pathwayM Colucci, F Incampo, A Cannavò, et al.
Blood|August 1, 1983
Generation of procoagulant activity by mononuclear phagocytes: a possible mechanism contributing to blood clotting activation within malignant tissuesR Lorenzet, G Peri, D Locati, et al.
Thrombosis Research|November 1, 1981
Cancer cell procoagulant: a novel vitamin K-dependent activityF Delaini, M Colucci, G De Bellis Vitti, et al.
International Journal of Oncology|May 17, 2011
Reduction of tumor-associated fibrinolytic-activity by antimetastatic dosages of 2 ru(ii)-dmso complexes in mice bearing lewis lung-carcinomaM Colucci, M Coluccia, P Montemurro, et al.
Journal of Thrombosis and Haemostasis : JTH|December 22, 2012
Effect of warfarin treatment on thrombin activatable fibrinolysis inhibitor (TAFI) activation and TAFI-mediated inhibition of fibrinolysisF Incampo, C Carrieri, R Galasso, et al.
Clinical & Experimental Metastasis|September 1, 1988
DMSO-induced changes in the procoagulant and fibrinolytic activity of B16 melanoma cells: influence on lung colony formationB Casali, M G Lampugnani, M Riganti, et al.
Thrombosis and Haemostasis|October 6, 2000
Fibrin down-regulates LPS- and PMA-induced tissue factor expression by blood mononuclear cellsM R Rossiello, A Italia, A M Stramaglia, et al.
Cancer Research|December 1, 1986
Cancer procoagulant in human tumor cells: evidence from melanoma patientsM B Donati, C Gambacorti-Passerini, B Casali, et al.
The Journal of Infectious Diseases|December 1, 1996
Effect of Helicobacter pylori lipopolysaccharide (LPS) and LPS derivatives on the production of tissue factor and plasminogen activator inhibitor type 2 by human blood mononuclear cellsN Semeraro, P Montemurro, C Piccoli, et al.
Thrombosis and Haemostasis|August 13, 1990
Unbalanced coagulation-fibrinolysis potential during L-asparaginase therapy in children with acute lymphoblastic leukaemiaN Semeraro, P Montemurro, P Giordano, et al.
Pageof 13

Showing results (111-120 of 130) with videos related to

Sort By:
Pageof 13
Journal of Thrombosis and Haemostasis : JTH|April 21, 2016
Reduced fibrinolytic resistance in patients with factor XI deficiency. Evidence of a thrombin-independent impairment of the thrombin-activatable fibrinolysis inhibitor pathwayM Colucci, F Incampo, A Cannavò, et al.
Blood|August 1, 1983
Generation of procoagulant activity by mononuclear phagocytes: a possible mechanism contributing to blood clotting activation within malignant tissuesR Lorenzet, G Peri, D Locati, et al.
Thrombosis Research|November 1, 1981
Cancer cell procoagulant: a novel vitamin K-dependent activityF Delaini, M Colucci, G De Bellis Vitti, et al.
International Journal of Oncology|May 17, 2011
Reduction of tumor-associated fibrinolytic-activity by antimetastatic dosages of 2 ru(ii)-dmso complexes in mice bearing lewis lung-carcinomaM Colucci, M Coluccia, P Montemurro, et al.
Journal of Thrombosis and Haemostasis : JTH|December 22, 2012
Effect of warfarin treatment on thrombin activatable fibrinolysis inhibitor (TAFI) activation and TAFI-mediated inhibition of fibrinolysisF Incampo, C Carrieri, R Galasso, et al.
Clinical & Experimental Metastasis|September 1, 1988
DMSO-induced changes in the procoagulant and fibrinolytic activity of B16 melanoma cells: influence on lung colony formationB Casali, M G Lampugnani, M Riganti, et al.
Thrombosis and Haemostasis|October 6, 2000
Fibrin down-regulates LPS- and PMA-induced tissue factor expression by blood mononuclear cellsM R Rossiello, A Italia, A M Stramaglia, et al.
Cancer Research|December 1, 1986
Cancer procoagulant in human tumor cells: evidence from melanoma patientsM B Donati, C Gambacorti-Passerini, B Casali, et al.
The Journal of Infectious Diseases|December 1, 1996
Effect of Helicobacter pylori lipopolysaccharide (LPS) and LPS derivatives on the production of tissue factor and plasminogen activator inhibitor type 2 by human blood mononuclear cellsN Semeraro, P Montemurro, C Piccoli, et al.
Thrombosis and Haemostasis|August 13, 1990
Unbalanced coagulation-fibrinolysis potential during L-asparaginase therapy in children with acute lymphoblastic leukaemiaN Semeraro, P Montemurro, P Giordano, et al.
Pageof 13